The 20 Best Transthyretin Amyloidosis Doctors Near Me in Ann Arbor, MI

Michael Shea is a Cardiologist and an Internal Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Shea is rated as an Experienced provider by MediFind in the treatment of Transthyretin Amyloidosis. He is also highly rated in 44 other conditions, according to our data. His clinical expertise encompasses Coronary Heart Disease, Atherosclerosis, Angina, Cardiac Ablation, and Pacemaker Implantation.

Venkatesh Murthy is a Cardiologist and a Radiologist practicing medicine in Ann Arbor, Michigan. Dr. Murthy is rated as an Experienced provider by MediFind in the treatment of Transthyretin Amyloidosis. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Coronary Heart Disease, Atherosclerosis, Sarcoidosis, Heart Transplant, and Percutaneous Coronary Intervention (PCI). Dr. Murthy is board certified in Internal Medicine and Cardiovascular Disease.

James Corbett is a Cardiologist and an Internal Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Corbett is rated as an Experienced provider by MediFind in the treatment of Transthyretin Amyloidosis. He is also highly rated in 31 other conditions, according to our data. His clinical expertise encompasses Ectopic Heartbeat, Ventricular Tachycardia, Coronary Heart Disease, Cardiomyopathy, and Heart Transplant. Dr. Corbett is board certified in Internal Medicine and Cardiovascular Disease.

Dr. Hummel is the Director for Heart Failure with Preserved Ejection (HFpEF) program at the Frankel Cardiovascular Center. The HFpEF clinical program incorporates multi-domain assessment and management, with the goals of improving quality of life and long-term outcomes while uncovering and treating the underlying causes of this complex syndrome. The Michigan Medicine HFpEF program also offers access to groundbreaking clinical trials which incorporate interventions ranging from dietary support and medications to implantable cardiac devices for HFpEF. In addition to industry-sponsored trials, Dr. Hummel’s own research has been funded by the NHLBI, NIA, AHRQ, and the VA. This work aims to understand the impact of diet on HFpEF development and progression, and to facilitate healthy eating through technological innovation.As part of the American College of Cardiology’s Geriatric Cardiology leadership council, Dr. Hummel also studies the importance of geriatric domains, such as malnutrition, frailty, and polypharmacy, in heart failure assessment and management. Dr. Hummel is rated as an Advanced provider by MediFind in the treatment of Transthyretin Amyloidosis. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Failure, Pulmonary Edema, Heart Transplant, and Cardiac Ablation. Dr. Hummel is board certified in Cardiovascular Disease and Advanced Heart Failure & Transplant Cardiology.

David Dyke is a Cardiologist and an Advanced Heart Failure and Transplant Cardiologist practicing medicine in Ann Arbor, Michigan. Dr. Dyke is rated as an Advanced provider by MediFind in the treatment of Transthyretin Amyloidosis. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy, Sarcoidosis, and Dilated Cardiomyopathy (DCM).

Salim Hayek is a Cardiologist practicing medicine in Ann Arbor,, Michigan. Dr. Hayek is rated as an Experienced provider by MediFind in the treatment of Transthyretin Amyloidosis. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses COVID-19, Myocarditis, Coronary Heart Disease, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

Todd Koelling joined the University of Michigan faculty in 1997. At present, Dr. Koelling is the Medical Director of Heart Failure and co-directs the Heart Failure and Heart Transplantation Management Program at the University of Michigan. He is a Professor in the Department of Internal Medicine. His research interests include heart failure quality improvement, heart failure management, and risk/prognosis assessment. He has studied targeted patient education interventions in heart failure patients and has directed community hospital quality improvement initiatives in the State of Michigan. He is committed to improving the quality of care provided to patients with advanced heart failure treated at the University of Michigan Health System. Dr. Koelling is rated as an Experienced provider by MediFind in the treatment of Transthyretin Amyloidosis. He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Heart Failure, Cardiomyopathy, Sarcoidosis, Heart Transplant, and Heart Valve Repair. Dr. Koelling is board certified in Advanced Heart Failure & Transplant Cardiology.

Jessica Golbus MD, MS is an Assistant Professor in the Division of Cardiovascular Medicine. She received her MD from the University of Michigan and completed her residency in Internal Medicine at the University of Pennsylvania. She then completed her training in General and Advanced Heart Failure and Transplant Cardiology at the University of Michigan. She also received her MS through the University of Michigan School of Public Health.Dr. Golbus is actively engaged in clinical practice in the areas of heart failure, heart transplantation, and mechanical circulatory support. Her research focuses on using digital health technology, like smartwatches, to improve the delivery of cardiovascular care and on optimizing treatments for patients with advanced heart failure. Dr. Golbus is rated as an Experienced provider by MediFind in the treatment of Transthyretin Amyloidosis. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Heart Failure, Cardiomyopathy, Pulmonary Edema, Cardiogenic Shock, and Heart Transplant. Dr. Golbus is board certified in Internal Medicine, Cardiovascular Disease, and Advanced Heart Failure & Transplant Cardiology.

Ann Little is a Neurologist and a Neuroradiologist practicing medicine in Ann Arbor, Michigan. Dr. Little is rated as an Experienced provider by MediFind in the treatment of Transthyretin Amyloidosis. She is also highly rated in 63 other conditions, according to our data. Her clinical expertise encompasses Inclusion Body Myositis, Polymyositis, Myasthenia Gravis, Stent Placement, and Transmyocardial Revascularization.

Erica Campagnaro is a Hematologist and an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Campagnaro is rated as an Experienced provider by MediFind in the treatment of Transthyretin Amyloidosis. She is also highly rated in 27 other conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Monoclonal Gammopathy of Undetermined Significance (MGUS), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Campagnaro is board certified in Internal Medicine and Hematology.

Dr. Lukela received her undergraduate degree from Duke University and her medical degree from Harvard Medical School. She completed her internal medicine residency at the University of Michigan in 2002 and spent an additional year there serving as one of the chief medical residents. Her clinical interests include preventive health, diabetes management and women’s health. Her research and academic interests include gender disparities in medicine and strategies for effective teaching in the outpatient setting. Dr. Lukela is rated as an Experienced provider by MediFind in the treatment of Transthyretin Amyloidosis. Her clinical expertise encompasses Maturity Onset Diabetes of the Young, Type 2 Diabetes (T2D), Chronic Myelomonocytic Leukemia (CMML), and Oral Herpes.

Robert A. Solomon, M.D. is a Clinical Assistant Professor in the Division of Cardiovascular Medicine and the Associate Director of Community Experience and Outreach for the U-M Health Frankel Cardiovascular Center. A native of Metro Detroit, he attended Hampton University and Howard University for his undergraduate and medical school education, respectively.Completing his residency training in Internal Medicine at Henry Ford Hospital, he then went on to finish his Cardiovascular Disease Fellowship training at Ascension St. John Hospital before returning to Henry Ford Hospital to complete his Advanced Heart Failure and Transplant Fellowship training. Dr. Solomon joined University of Michigan Health in August 2023 and as a member of Michigan Medicine his clinical interests include general cardiology, heart failure with preserved ejection fraction and cardiac amyloidosis. His additional interests include patient health literacy and community outreach. Dr. Solomon is rated as an Experienced provider by MediFind in the treatment of Transthyretin Amyloidosis. His clinical expertise encompasses Heart Failure, Heart Failure with Preserved Ejection Fraction (HFpEF), Pulmonary Edema, and Transthyretin Amyloid Cardiomyopathy. Dr. Solomon is board certified in Cardiovascular Disease, Internal Medicine, and Advanced Heart Failure & Transplant Cardiology.

Dr. Troy LaBounty is a cardiologist at Michigan Medicine’s Cardiovascular Center and Chelsea Health Center. He enjoys working with patients to prevent, diagnose, and treat heart disease, and believes a patient and their doctor should work together as a team to address their cardiac issues. He sees patients with a variety of cardiac conditions and has a clinical focus in heart valve disease. He has published and lectured extensively on the use of cardiac imaging to diagnose and manage patients with coronary artery disease and heart valve disease, and has expertise in cardiac CT, transthoracic echocardiography, and transesophageal echocardiography.A native of Iowa, Troy was working on his doctorate in cello performance before changing direction to pursue a career in medicine. He completed medical school at SUNY Stony Brook and his residency and fellowship training at the University of Michigan. After training, he became a faculty cardiologist at NY Presbyterian/Cornell Medical College in New York City and then Cedars-Sinai Medical Center in Los Angeles before returning to Michigan Medicine. Troy enjoys outdoor activities like backpacking and camping and is an avid outdoor runner. Dr. Labounty is rated as an Experienced provider by MediFind in the treatment of Transthyretin Amyloidosis. He is also highly rated in 63 other conditions, according to our data. His clinical expertise encompasses Aortic Valve Stenosis, Coronary Heart Disease, Cardiomyopathy, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).